郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives.

期刊：Biomaterials发表年份：2005作者：Alessandro Dalpiaz; Eliana Leo; Federica Vitali; Barbara Pavan; Angelo Scatturin; Fabrizio Bortolotti; Stefano Manfredini; Elisa Durini; Flavio Forni; Barbara Brina; Maria Angela Vandelli
阅读更多 →

药效评价Quantitatively distinct requirements for signaling-competent cell spreading on engineered versus natural adhesion ligands.

期刊：Journal of controlled release : official journal of the Controlled Release Society发表年份：2005作者：Gabriel P Richman; David A Tirrell; Anand R Asthagiri
阅读更多 →

药效评价Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.

期刊：Journal of medicinal chemistry发表年份：2005作者：Stefano Moro; Paolo Braiuca; Francesca Deflorian; Cristina Ferrari; Giorgia Pastorin; Barbara Cacciari; Pier Giovanni Baraldi; Katia Varani; Pier Andrea Borea; Giampiero Spalluto
阅读更多 →

药效评价Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

期刊：The Journal of biological chemistry发表年份：2005作者：Matthew L Hemming; Dennis J Selkoe
阅读更多 →